Immunotherapy was a game-changer for the cancer field, but immunotherapies using cytokines like IL-2 often cause severe side effects. Researchers are developing a newly engineered blueprint to improve the therapeutic efficacy and safety of IL-2 and other cytokines.
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.